Firmagon degarelix: Phase IIIb started

Ferring began the single-blind, North American Phase IIIb PRONOUNCE trial to compare Firmagon to Lupron Depot leuprolide for 1 year in about 900 patients with prostate cancer and CV disease. Firmagon...